NDC 0169-1715 – Ozempic
Semaglutide 1.5 mg/1 · Tablet · Oral
Product NDC0169-1715
Product details
- Brand name
- Ozempic
- Generic name
- Oral semaglutide
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA213051
- Marketed since
- April 27, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- GLP-1 Receptor Agonist
Active ingredients
- Semaglutide 1.5 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0169-1715-30 | 30 TABLET in 1 BOTTLE, PLASTIC (0169-1715-30) | Apr 27, 2026 |
| 0169-1715-90 sample | 30 TABLET in 1 BOTTLE, PLASTIC (0169-1715-90) | Apr 27, 2026 |
Recalls mentioning this NDC
- D-0536-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Other Ozempic products
- 0169-1704 Semaglutide 4 mg/1 · Tablet · Novo Nordisk Pharmaceutical Industries, LP
- 0169-1709 Semaglutide 9 mg/1 · Tablet · Novo Nordisk Pharmaceutical Industries, LP
- 50090-5949 Semaglutide 1.34 mg/mL · Injection, Solution · A-S Medication Solutions
- 50090-6051 Semaglutide 2.68 mg/mL · Injection, Solution · A-S Medication Solutions
- 50090-8027 Semaglutide .68 mg/mL · Injection, Solution · A-S Medication Solutions
- 0169-4130 Semaglutide 1.34 mg/mL · Injection, Solution · Novo Nordisk Pharmaceutical Industries, LP
- 0169-4181 Semaglutide .68 mg/mL · Injection, Solution · Novo Nordisk Pharmaceutical Industries, LP
- 0169-4772 Semaglutide 2.68 mg/mL · Injection, Solution · Novo Nordisk Pharmaceutical Industries, LP